JBC PeproTech; Our Business is Cytokines!

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bashford, C. L.
Right arrow Articles by Pasternak, C. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bashford, C. L.
Right arrow Articles by Pasternak, C. A.
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J. Biol. Chem., Vol. 261, Issue 20, 9300-9308, 07, 1986

Membrane damage by hemolytic viruses, toxins, complement, and other cytotoxic agents. A common mechanism blocked by divalent cations

CL Bashford, GM Alder, G Menestrina, KJ Micklem, JJ Murphy and CA Pasternak

Hemolytic viruses, bacterial and animal toxins, the components of activated complement, cationic proteins, and detergents induce a sequence of permeability changes at the plasma membrane that are in every case sensitive to changes in ionic strength and to divalent cations. Individually, each agent exhibits positive cooperativity; when two agents are present together, they show synergy. It is concluded that such cytotoxic agents damage membranes by a common mechanism. Hence permeability changes are unlikely to depend on the formation of specific, protein-lined channels, as previously envisaged in the case of activated complement or certain bacterial toxins.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 J. Virol.Home page
A. N. Chanturiya, G. Basanez, U. Schubert, P. Henklein, J. W. Yewdell, and J. Zimmerberg
PB1-F2, an Influenza A Virus-Encoded Proapoptotic Mitochondrial Protein, Creates Variably Sized Pores in Planar Lipid Membranes
J. Virol., June 15, 2004; 78(12): 6304 - 6312.
[Abstract] [Full Text] [PDF]

Home page
 J Med MicrobiolHome page
T. MONODANE, Y. KAWABATA, S. YANG, S. HASE, and H. TAKADA
Induction of necrosis factor-{alpha} and interleukin-6 in mice in vivo and in murine peritoneal macrophages and human whole blood cells in vitro by Micrococcus luteus teichuronic acids
J. Med. Microbiol., January 1, 2001; 50(1): 4 - 12.
[Abstract] [Full Text] [PDF]

Home page
 MicrobiologyHome page
D. J. Beecher and A. C. L. Wong
Cooperative, synergistic and antagonistic haemolytic interactions between haemolysin BL, phosphatidylcholine phospholipase C and sphingomyelinase from Bacillus cereus
Microbiology, December 1, 2000; 146(12): 3033 - 3039.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
L. Rink and H. Kirchner
Zinc-Altered Immune Function and Cytokine Production
J. Nutr., May 1, 2000; 130(5): 1407S - 1411.
[Abstract] [Full Text]

Home page
 JAMAHome page
M. L. Macknin, M. Piedmonte, C. Calendine, J. Janosky, and E. Wald
Zinc Gluconate Lozenges for Treating the Common Cold in Children: A Randomized Controlled Trial
JAMA, June 24, 1998; 279(24): 1962 - 1967.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 1986 by the American Society for Biochemistry and Molecular Biology.